0,866  0,008  Antiinflammatory
0,805  0,016  Apoptosis agonist
0,786  0,004  Antineurogenic pain
0,754  0,004  P-glycoprotein inhibitor
0,698  0,006  Cardiovascular analeptic
0,701  0,013  Analgesic
0,679  0,006  Nitric oxide antagonist
0,653  0,005  Antineoplastic enhancer
0,649  0,011  Sensitization
0,619  0,006  Angiogenesis stimulant
0,621  0,011  Immunosuppressant
0,622  0,021  Antileukemic
0,568  0,029  Alzheimer's disease treatment
0,530  0,008  UGT1A4 substrate
0,525  0,004  Antifungal enhancer
0,558  0,043  Caspase 9 stimulant
0,527  0,017  Antifungal
0,526  0,025  Respiratory analeptic
0,510  0,025  Bone diseases treatment
0,531  0,047  Antineoplastic (breast cancer)
0,499  0,020  FMO1 substrate
0,496  0,021  Antiosteoporotic
0,498  0,034  Antipruritic, allergic
0,494  0,036  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,462  0,008  Diabetic retinopathy treatment
0,462  0,013  Myocardial infarction treatment
0,450  0,006  Antialcoholic
0,448  0,005  Acaricide
0,471  0,032  CYP2C19 substrate
0,460  0,029  Spasmolytic
0,431  0,004  Vanilloid agonist
0,466  0,043  CYP2C9 substrate
0,433  0,010  Contraceptive
0,440  0,019  Antidiabetic symptomatic
0,469  0,049  Transcription factor NF kappa B inhibitor
0,469  0,055  TNF expression inhibitor
0,424  0,011  Antiparkinsonian, rigidity relieving
0,437  0,030  Analeptic
0,437  0,031  Radioprotector
0,442  0,038  5 Hydroxytryptamine release stimulant
0,420  0,018  Calcium channel activator
0,424  0,028  NOS2 expression inhibitor
0,401  0,012  Antihypotensive
0,415  0,034  ICAM1 expression inhibitor
0,396  0,017  Abortion inducer
0,391  0,016  5 Hydroxytryptamine uptake stimulant
0,394  0,031  Antiprotozoal (Leishmania)
0,375  0,014  Antiviral (Influenza)
0,389  0,029  Antiglaucomic
0,368  0,014  Antiacne
0,385  0,034  UGT2B4 substrate
0,385  0,042  Antineoplastic (pancreatic cancer)
0,352  0,011  Antiviral (Influenza A)
0,367  0,030  Antiparasitic
0,348  0,012  Protein kinase stimulant
0,356  0,032  Antineoplastic (liver cancer)
0,344  0,024  Antihelmintic
0,361  0,048  Antiepileptic
0,328  0,016  Prostate disorders treatment
0,380  0,068  CYP3A4 substrate
0,314  0,005  ATPase inhibitor
0,376  0,070  Ulceration
0,322  0,016  Cholinergic
0,325  0,022  UGT2B7 substrate
0,320  0,019  Pneumotoxic
0,325  0,027  RNA-directed DNA polymerase inhibitor
0,327  0,032  GST M1-1 substrate
0,337  0,047  Chemoprotective
0,305  0,019  Interferon gamma antagonist
0,323  0,041  Vascular (periferal) disease treatment
0,320  0,038  Psychostimulant
0,297  0,019  Neurotrophic factor enhancer
0,300  0,022  Antipruritic, non-allergic
0,289  0,014  Acetylcholinesterase inhibitor
0,294  0,020  CYP2B6 inhibitor
0,336  0,063  AR expression inhibitor
0,350  0,080  Antineoplastic (lung cancer)
0,335  0,065  Immunomodulator
0,272  0,004  Antihypermotility
0,271  0,004  Cannabinoid CB2 receptor antagonist
0,266  0,004  Actinic keratosis treatment
0,345  0,088  GST A substrate
0,277  0,021  UGT2B15 substrate
0,289  0,035  UGT1A1 substrate
0,311  0,058  Antioxidant
0,337  0,093  GABA C receptor rho-3 antagonist
0,287  0,044  Transplant rejection treatment
0,276  0,034  VCAM1 expression inhibitor
0,311  0,071  Antipsoriatic
0,265  0,026  Anesthetic
0,310  0,073  Antineoplastic (brain cancer)
0,300  0,063  FMO3 substrate
0,241  0,006  TRPA1 agonist
0,283  0,050  DNA synthesis inhibitor
0,263  0,030  Lipocortins synthesis antagonist
0,252  0,020  UGT2B9 substrate
0,349  0,116  5 Hydroxytryptamine release inhibitor
0,239  0,009  Contraceptive female
0,245  0,015  UGT2B10 substrate
0,285  0,056  Interleukin agonist
0,259  0,030  Antianorexic
0,277  0,051  Gastrin inhibitor
0,287  0,065  Teratogen
0,268  0,048  Chemopreventive
0,290  0,072  CYP1A2 substrate
0,224  0,007  Postmenopausal disorders treatment
0,262  0,045  UDP-glucuronosyltransferase substrate
0,228  0,013  Antifungal (Cryptococcus)
0,226  0,015  Microtubule formation inhibitor
0,219  0,013  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,232  0,030  Skin irritative effect
0,216  0,018  Antismoking
0,217  0,019  Arachidonic acid antagonist
0,218  0,022  Antirickettsial
0,247  0,051  Sedative
0,271  0,075  Aldehyde oxidase inhibitor
0,290  0,095  Antithrombotic
0,278  0,085  CTGF expression inhibitor
0,262  0,069  Embryotoxic
0,225  0,033  Melanin inhibitor
0,264  0,073  Flavin-containing monooxygenase substrate
0,198  0,009  Transcription factor NF kappa B stimulant
0,279  0,092  Hepatic disorders treatment
0,243  0,056  Carcinogenic
0,247  0,061  Antiulcerative
0,199  0,014  Adenylate cyclase stimulant
0,256  0,072  Proliferative diseases treatment
0,222  0,039  Antiviral (Herpes)
0,280  0,098  Sodium/bile acid cotransporter inhibitor
0,202  0,021  Farnesoid X receptor antagonist
0,274  0,094  CYP2D6 substrate
0,189  0,009  Cannabinoid receptor antagonist
0,200  0,021  Retinoprotector
0,182  0,004  Sphingosine 1-phosphate receptor 3 agonist
0,217  0,045  Eye irritation, high
0,179  0,007  Anabolic
0,185  0,016  Vanilloid 1 agonist
0,222  0,054  Hepatoprotectant
0,215  0,048  Prostatic (benign) hyperplasia treatment
0,171  0,005  Sphingosine 1-phosphate receptor 5 agonist
0,195  0,034  Anesthetic local
0,172  0,011  Ca2+-transporting ATPase inhibitor
0,245  0,086  UGT1A9 substrate
0,227  0,068  Cytotoxic
0,269  0,112  Cholesterol antagonist
0,174  0,017  Androgen antagonist
0,232  0,075  Cytostatic
0,167  0,010  Cannabinoid receptor agonist
0,237  0,082  Tyrosine 3 hydroxylase inhibitor
0,228  0,073  UGT1A6 substrate
0,190  0,035  SULT1A3 substrate
0,251  0,098  Antihypoxic
0,206  0,053  Muscle relaxant
0,180  0,027  Ferrochelatase inhibitor
0,194  0,042  Phobic disorders treatment
0,293  0,141  Antibacterial
0,242  0,090  Amyotrophic lateral sclerosis treatment
0,179  0,027  Hearing loss treatment
0,160  0,009  Cannabinoid CB2 receptor agonist
0,179  0,031  Movement disorders treatment
0,187  0,038  Alpha-N-acetylglucosaminidase inhibitor
0,174  0,025  SULT1A1 substrate
0,206  0,060  Sigma receptor agonist
0,166  0,019  Antiviral (Papilloma)
0,249  0,103  Antineoplastic (colorectal cancer)
0,280  0,136  Antineoplastic (myeloid leukemia)
0,191  0,048  Hair growth stimulant
0,157  0,014  GST T1-1 substrate
0,242  0,098  Antineoplastic (colon cancer)
0,256  0,113  Interleukin 2 agonist
0,155  0,013  UGT2B11 substrate
0,194  0,053  Succinate dehydrogenase inhibitor
0,150  0,010  Tourette's syndrome treatment
0,225  0,087  Antineoplastic (cervical cancer)
0,156  0,020  Posttraumatic stress disorder treatment
0,199  0,064  5 Hydroxytryptamine 3E antagonist
0,147  0,012  Ornithine decarboxylase inhibitor
0,170  0,036  Cholesterol synthesis inhibitor
0,155  0,020  Myasthenia Gravis treatment
0,168  0,034  Autism spectrum disorders treatment
0,243  0,109  NOS3 expression inhibitor
0,172  0,039  DNA polymerase I inhibitor
0,201  0,070  Non-steroidal antiinflammatory agent
0,137  0,009  Glycine receptor agonist
0,159  0,031  GABA C receptor agonist
0,142  0,014  Aromatase inhibitor
0,139  0,012  Cannabinoid CB1 receptor agonist
0,144  0,017  Inducible nitric-oxide synthase inhibitor
0,220  0,094  Antipyretic
0,175  0,050  CNS active muscle relaxant
0,155  0,030  Choleretic
0,147  0,023  Prolactin inhibitor
0,140  0,018  Antidote, mercury
0,272  0,152  CYP2C19 inhibitor
0,173  0,053  Antiparkinsonian, tremor relieving
0,121  0,004  Postcoital contraceptive
0,153  0,036  Menstruation disorders treatment
0,224  0,108  Antineoplastic (melanoma)
0,256  0,141  Antineoplastic (endocrine cancer)
0,194  0,079  Insulin sensitizer
0,152  0,040  Growth stimulant
0,175  0,064  Antihelmintic (Nematodes)
0,160  0,051  Neurotrophic factor
0,146  0,037  Sphingosine 1-phosphate receptor 4 antagonist
0,258  0,149  Histamine release inhibitor
0,116  0,008  Vanilloid 4 agonist
0,119  0,011  Cannabinoid CB1 receptor antagonist
0,217  0,111  Antineoplastic (ovarian cancer)
0,122  0,018  ATPase (Vacuolar H+) inhibitor
0,120  0,016  Na+ K+ transporting ATPase inhibitor
0,152  0,050  Pregnane X receptor agonist
0,125  0,025  CYP2A6 inhibitor
0,105  0,007  Nicotinic alpha3beta2 receptor antagonist
0,119  0,022  Keratolytic
0,152  0,054  Carcinogenic, group 3
0,110  0,013  Bcl2 antagonist
0,108  0,012  Androgen agonist
0,144  0,048  Protein-tyrosine phosphatase 1B inhibitor
0,165  0,072  UGT1A3 substrate
0,148  0,057  Antieczematic
0,181  0,091  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,099  0,009  SULT2A1 substrate
0,160  0,071  Antimutagenic
0,158  0,071  Carcinogenic, group 1
0,129  0,044  GABA C receptor antagonist
0,142  0,058  Antiseptic
0,088  0,005  Adenylate cyclase 1 inhibitor
0,099  0,016  Antidote, organophosphates
0,179  0,097  Antimitotic
0,162  0,080  Mutagenic
0,111  0,030  Bile acid receptor antagonist
0,129  0,048  Excitatory amino acid transporter EAAC1 inhibitor
0,088  0,008  Anesthetic inhalation
0,102  0,023  Narcotic antagonist
0,106  0,027  Glycine receptor antagonist
0,101  0,021  Sleep apnea treatment
0,083  0,004  Parathyroid hormone antagonist
0,122  0,043  Antiprotozoal (Toxoplasma)
0,117  0,039  Antineoplastic antibiotic
0,130  0,051  Alcohol dehydrogenase substrate
0,127  0,050  Antifungal (Pneumocystis)
0,188  0,112  Antihypercholesterolemic
0,087  0,011  Heme oxygenase stimulant
0,111  0,036  Antispirochetal
0,131  0,057  Beta amyloid protein antagonist
0,164  0,092  LDLR expression enhancer
0,148  0,076  Insulin secretagoues
0,168  0,096  Anesthetic general
0,082  0,010  Aldosterone antagonist
0,174  0,103  Cardiodepressant
0,078  0,007  Pregnane X receptor antagonist
0,078  0,008  Retinoid X receptor agonist
0,130  0,060  Coagulant
0,082  0,012  5-Alpha-reductase inhibitor
0,181  0,111  Antineoplastic (glioma)
0,133  0,064  Antihyperlipoproteinemic
0,083  0,015  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,127  0,060  Antitussive
0,086  0,019  Glutamate (mGluR6) antagonist
0,112  0,044  Nitric-oxide synthase inhibitor
0,096  0,030  Estrogen-related receptor beta agonist
0,143  0,077  Genotoxic
0,117  0,052  Antiviral (Poxvirus)
0,147  0,082  CF transmembrane conductance regulator agonist
0,097  0,033  Nicotinic alpha4beta2 receptor antagonist
0,072  0,009  Nicotinic acid receptor 2 agonist
0,067  0,004  Retinoid X receptor antagonist
0,088  0,025  Anticholelithogenic
0,102  0,040  Glutamate release inhibitor
0,101  0,039  Acetylcholine nicotinic antagonist
0,114  0,053  UGT2B1 substrate
0,066  0,006  CXC chemokine 3 receptor antagonist
0,116  0,057  Carcinogenic, group 2B
0,063  0,005  Tubulin agonist
0,066  0,009  Microtubule stabilization
0,211  0,154  Caspase 3 stimulant
0,067  0,010  Retinoid X alpha receptor agonist
0,079  0,022  Transcription factor AP-1 inhibitor
0,181  0,125  Nitric-oxide synthase stimulant
0,092  0,036  Interferon agonist
0,159  0,103  Antiviral (Hepatitis)
0,068  0,013  Progesterone antagonist
0,101  0,047  Paget's disease treatment
0,230  0,176  Antiobesity
0,142  0,087  Protein-tyrosine phosphatase inhibitor
0,058  0,004  Retinoid X alpha receptor antagonist
0,078  0,025  Interferon inducer
0,103  0,051  Lanosterol 14 alpha demethylase inhibitor
0,055  0,003  Progesterone receptor B antagonist
0,115  0,064  Photosensitizer
0,061  0,011  Guanylate cyclase inhibitor
0,079  0,029  Glutamate (mGluR7) antagonist
0,071  0,022  Prolactin release inhibitor
0,095  0,046  Tocolytic
0,058  0,009  Alpha 1L adrenoreceptor agonist
0,099  0,051  ABCA1 expression enhancer
0,050  0,003  Vanilloid 2 agonist
0,050  0,004  Nicotinic acid receptor 2 antagonist
0,057  0,011  GABA uptake inhibitor
0,118  0,072  Antiviral (Influenza B)
0,107  0,061  Expectorant
0,072  0,026  Calcium channel T-type blocker
0,230  0,186  Analgesic, non-opioid
0,073  0,029  Hypercalcemia treatment
0,096  0,053  Antithrombocytopenic
0,065  0,022  Aconitate hydratase inhibitor
0,177  0,135  Immunostimulant
0,047  0,005  Adenosine uptake inhibitor
0,073  0,032  Antihemophilic
0,066  0,025  Lipocortins synthesis agonist
0,086  0,046  T cell inhibitor
0,067  0,027  Estrogen agonist
0,049  0,009  Vanilloid 3 antagonist
0,066  0,027  Protein 50S ribosomal subunit inhibitor
0,104  0,065  Glutathione S-transferase substrate
0,070  0,032  Antimycoplasmal
0,052  0,014  Nicotinic acid receptor agonist
0,103  0,066  Antifungal (Aspergillus)
0,058  0,021  Mineralocorticoid receptor antagonist
0,052  0,015  Alpha 1d adrenoreceptor agonist
0,072  0,035  Uterine relaxant
0,090  0,054  Carcinogenic, group 2A
0,054  0,017  Sphingosine 1-phosphate receptor 1 agonist
0,121  0,085  Cocaine dependence treatment
0,076  0,040  Neuronal nicotinic receptor antagonist
0,165  0,129  VEGF expression inhibitor
0,048  0,013  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,106  0,071  Antiviral (Coronavirus)
0,106  0,071  Antiviral (SARS coronavirus)
0,109  0,074  Mental retardation treatment
0,088  0,054  Sodium/hydrogen exchanger 5 inhibitor
0,041  0,007  Retinoid X gamma receptor agonist
0,061  0,028  Nicotinic receptor alpha7 subunit antagonist
0,074  0,041  Sphingosine 1-phosphate receptor 4 agonist
0,177  0,146  Superoxide dismutase inhibitor
0,090  0,059  Triose-phosphate isomerase inhibitor
0,096  0,066  UDP-glucose 4-epimerase inhibitor
0,047  0,017  Retinoic acid alpha receptor agonist
0,053  0,023  Sphingosine 1-phosphate receptor agonist
0,091  0,061  Thioredoxin inhibitor
0,148  0,118  Toxic, respiratory center
0,135  0,107  Uterine stimulant
0,036  0,008  Retinoic acid receptor agonist
0,145  0,117  Phospholipase C inhibitor
0,077  0,050  GABA aminotransferase inhibitor
0,068  0,041  Hyperparathyroidism treatment
0,101  0,074  5 Hydroxytryptamine 3A agonist
0,104  0,078  Acetylcholine release stimulant
0,046  0,020  Kainate receptor agonist
0,034  0,008  Retinoid X gamma receptor antagonist
0,105  0,080  Proteasome inhibitor
0,097  0,073  Adenylate kinase inhibitor
0,043  0,019  Potassium channel Kv1.1 blocker
0,124  0,100  Diuretic
0,028  0,005  Retinoid X beta receptor antagonist
0,045  0,022  Dopamine D5 agonist
0,198  0,175  CYP3A4 inhibitor
0,136  0,113  Antiviral (Hepatitis C)
0,074  0,052  Antibiotic
0,029  0,007  Retinoic acid gamma receptor agonist
0,093  0,072  Antifungal (Candida)
0,182  0,161  Transcription factor STAT3 inhibitor
0,085  0,064  NADH dehydrogenase inhibitor
0,028  0,007  Retinoic acid alpha receptor antagonist
0,086  0,066  Potassium channel activator
0,087  0,067  Restless leg syndrome treatment
0,037  0,017  RNA-directed RNA polymerase stimulant
0,029  0,009  Retinoid X beta receptor agonist
0,027  0,008  Progesterone agonist
0,063  0,045  Calcium channel P-type blocker
0,144  0,126  Antineoplastic (glioblastoma multiforme)
0,091  0,072  Electrolyte absorption antagonist
0,028  0,010  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,059  0,041  Biliverdin reductase inhibitor
0,042  0,024  Membrane dipeptidase inhibitor
0,128  0,110  GABA C receptor rho-2 antagonist
0,045  0,028  Geranyltranstransferase inhibitor
0,035  0,017  Endothelial nitric-oxide synthase inhibitor
0,026  0,009  Vitamin D receptor antagonist
0,026  0,010  5-Alpha-reductase 2 inhibitor
0,022  0,006  Telomerase stimulant
0,030  0,013  Hedgehog signaling activator
0,025  0,009  5-Alpha-reductase 1 inhibitor
0,019  0,004  Progesterone receptor A antagonist
0,080  0,065  Antineoplastic alkaloid
0,023  0,009  Retinoic acid receptor antagonist
0,048  0,033  Glucose-6-phosphate isomerase inhibitor
0,031  0,017  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,074  0,060  Estrogen receptor alpha antagonist
0,023  0,009  Retinoic acid beta receptor agonist
0,047  0,033  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,097  0,083  DOPA decarboxylase inhibitor
0,025  0,012  GRP78 expression inhibitor
0,107  0,094  Cathepsin H inhibitor
0,131  0,118  Heat shock protein 70 antagonist
0,058  0,046  Potassium channel intermediate-conductance Ca-activated blocker
0,019  0,007  NMDA receptor phencyclidine site antagonist
0,089  0,078  Sulfotransferase substrate
0,033  0,021  Glutamate (mGluR3) agonist
0,069  0,058  Acetylcholine M4 receptor antagonist
0,068  0,057  Porphobilinogen synthase inhibitor
0,094  0,084  Cystathionine beta-synthase inhibitor
0,079  0,069  CC chemokine 5 receptor agonist
0,135  0,125  Platelet adhesion inhibitor
0,068  0,058  Phospholipase D inhibitor
0,030  0,021  Nicotinic alpha3beta4 receptor agonist
0,047  0,038  HCV NS3/NS4A protease inhibitor
0,032  0,023  Glucocorticoid antagonist
0,101  0,092  Antiprotozoal (Babesia)
0,036  0,028  Delayed rectifier potassium channel blocker
0,037  0,029  Glutamate (mGluR8) agonist
0,070  0,063  SULT1A2 substrate
0,041  0,035  Heme oxygenase inhibitor
0,123  0,117  Sphingosine 1-phosphate receptor 5 antagonist
0,030  0,025  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,061  0,056  Phosphofructokinase-1 inhibitor
0,029  0,026  ATP citrate lysase inhibitor
0,065  0,061  Aminopeptidase I inhibitor
0,087  0,084  GABA C receptor rho-1 antagonist
0,034  0,031  TRPM8 blocker
0,016  0,013  Vitamin D receptor agonist
0,071  0,068  Chymotrypsin inhibitor
0,048  0,045  Acyl-CoA dehydrogenase inhibitor
0,091  0,089  Antihelmintic (Fasciola)
0,034  0,032  Farnesoid X receptor agonist
0,102  0,101  Transcription factor STAT6 inhibitor
0,036  0,035  5 Hydroxytryptamine 2B agonist
0,041  0,040  Potassium channel Kv1.3 blocker
0,019  0,018  Corticosteroid-like
0,063  0,063  Protein kinase C beta inhibitor
0,041  0,041  Glutamate (mGluR5) agonist
0,103  0,103  Bone formation stimulant

